SUN PHARMACEUTICAL INDUSTRIES
Back to Balance Sheet
|
SUN PHARMACEUTICAL INDUSTRIES Last 5 Year Net Current Assets History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹41,238 Cr | ₹34,400 Cr | ₹26,449 Cr | ₹19,956 Cr | ₹17,656 Cr |
What is the latest Net Current Assets ratio of SUN PHARMACEUTICAL INDUSTRIES ?
| Year | Net Current Assets |
|---|---|
| Mar2026 | ₹41,238 Cr |
| Mar2025 | ₹34,400 Cr |
| Mar2024 | ₹26,449 Cr |
| Mar2023 | ₹19,956 Cr |
| Mar2022 | ₹17,656 Cr |
How is Net Current Assets of SUN PHARMACEUTICAL INDUSTRIES Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2026 | ₹41,238 Cr | 19.88 | |
| Mar2025 | ₹34,400 Cr | 30.06 | |
| Mar2024 | ₹26,449 Cr | 32.54 | |
| Mar2023 | ₹19,956 Cr | 13.02 | |
| Mar2022 | ₹17,656 Cr | - | |
Compare Net Current Assets of peers of SUN PHARMACEUTICAL INDUSTRIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUN PHARMACEUTICAL INDUSTRIES | ₹434,273.3 Cr | -2.4% | -6.2% | 11.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹246,737.0 Cr | -3.3% | 1.4% | 57.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹181,129.0 Cr | -4.5% | -4% | 35.9% | Stock Analytics | |
| CIPLA | ₹108,808.0 Cr | -3.6% | -5% | -10.6% | Stock Analytics | |
| MANKIND PHARMA | ₹104,376.0 Cr | 2.1% | 7.1% | -0.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,170.0 Cr | -0.2% | 2.5% | -3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUN PHARMACEUTICAL INDUSTRIES | -2.4% |
-6.2% |
11.8% |
| SENSEX | -2.3% |
-6.6% |
-12% |
You may also like the below Video Courses